In 2026, the UAE’s health tech landscape matured from a region of potential into a global epicentre for AI and medicine, shaped by rapid digital transformation.

Historically, mainland companies required a local Emirati partner holding 51% ownership. That changed in 2021, when the UAE introduced reforms enabling 100% foreign ownership across many commercial activities. For startups, this has removed a major barrier, making mainland incorporation significantly more attractive than before.

Freezones, on the other hand, have long offered full foreign ownership, along with simplified setup processes and sector-specific ecosystems. The distinction today is less about ownership and more about market access, regulation and scale.

Mainland is all about market access 

Setting up on the mainland allows startups to operate freely across the UAE market without restrictions. This is particularly relevant for health tech companies that need to engage directly with hospitals, clinics, insurers, and government entities.

Related:Building the Next Generation of Healthcare and Laboratory Leaders

Mainland businesses can also bid for government contracts, an important advantage in a region where public healthcare systems play a significant role. For startups, proximity to large healthcare networks can accelerate adoption and partnerships.

Freezones: Ecosystems built for innovation

Dubai’s freezones are designed to attract specific industries, offering tailored licensing, infrastructure, and support. For health tech startups, several zones stand out:

Related:GCC health leaders urge action to close meningitis B protection gap in high-risk adults

Each of these zones offers benefits such as tax efficiencies, simplified visa processes, and access to industry-specific networks. More importantly, they provide clarity in licensing, critical in a sector where compliance can define speed to market.

Related:UAE extends mental health support

Regulatory considerations

The regulatory pathway for startups, depends on the nature of the product or service. For example, a telemedicine platform may require approval from the Dubai Health Authority (DHA), while a wearable health device could fall under different standards.

Freezones like DHCC offer integrated regulatory support, which can simplify compliance for startups entering the healthcare space. Mainland companies, while more flexible in market access, may need to navigate through multiple authorities.

Data protection is another critical factor. With increasing emphasis on patient data privacy, startups must ensure compliance with UAE data protection laws and any sector-specific requirements.

Choosing the right path

For early-stage health tech startups, the decision often comes down to focus.

If the priority is innovation, product development, and access to a specialised ecosystem, freezones offer a supportive environment with lower initial complexity. If the goal is market penetration, partnerships with healthcare providers, and direct commercial activity across the UAE, the mainland provides greater flexibility and reach.

Dubai Healthcare City is unique in a way that sits somewhat in between offering both a specialised ecosystem and the ability to operate within a regulated healthcare framework.

There is no one-size-fits-all answer. The introduction of 100% foreign ownership on the mainland has levelled the playing field, but freezones continue to provide strategic advantages through industry focus and streamlined processes. 

The optimal choice depends on where they sit between innovation and implementation. Those building the future of healthcare may start in a freezone but scaling that vision across the UAE often leads them to the mainland.